Infections can also disseminate from adjacent tissues, such as the nasal cavity
After 36 weeks, the 0.5 mg retatrutide group showed a 3.19% body weight reduction, the 4 mg group showed a 10.37% decrease, the 8 and 12 mg groups demonstrated decreases of 16.81% and 16.94% respectively, which were significantly greater than those observed with placebo (3.00%) and 1.5 mg dulaglutide (2.02%) [114]
If you're considering weight loss injections instead of tablets, that option remains available too, and the clinical team can help you weigh up which is the better fit
FDA Approves Oral Semaglutide (Rybelsus) for CV Risk Reduction in Type 2 Diabetes FDA Approves Oral Semaglutide (Rybelsus) for CV Risk Reduction in Type 2 Diabetes On October 17, 2025, the FDA announced their approval of oral semaglutide, which is now the first oral GLP-1 approved for major adverse cardiovascular events in adult patients with T2D